Back to Search
RYAN LEBARON, M.D.
M.D.
Vascular & Interventional Radiology Physician
NPI: 1053638981IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology Physician
Radiology — Diagnostic Radiology
Code: 2085R0202X
37154(NE)19035A(WY)DR.0075798(CO)
Vascular & Interventional Radiology PhysicianPrimary
Radiology — Vascular & Interventional Radiology
Code: 2085R0204X
MD2013-0574(NM)
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
C-terminal fragment of transforming growth factor beta-induced protein (TGFBIp) is required for apoptosis in human osteosarcoma cells.
PMID 19505574·Matrix Biol·2009
8-other
Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice.
PMID 19592463·Arterioscler Thromb Vasc Biol·2009
4-observational
The accumulation of versican in the nodules of benign prostatic hyperplasia.
PMID 18819099·Prostate·2009
8-other
Prevalence of diabetes mellitus and correlation of urinary transforming growth factor-beta1 with blood hemoglobin A1C in the Atascosa Diabetes Study.
PMID 18646321·Ethn Dis·2008
8-other
Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells.
PMID 17226775·J Cell Biochem·2007
7-preclinical
Differences in the magnitude of long-term potentiation produced by theta burst and high frequency stimulation protocols matched in stimulus number.
PMID 15878145·Brain Res Brain Res Protoc·2005
7-preclinical
Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation.
PMID 15659705·Biol Reprod·2005
7-preclinical
A focal adhesion-like process underlies induction of long-term potentiation in the Schaffer collateral-CA1 region of the hippocampus.
PMID 18634595·Neuron Glia Biol·2004
8-other
In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels.
PMID 15227668·J Biomed Mater Res A·2004
7-preclinical
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.
PMID 15073129·Clin Cancer Res·2004
8-other
Modulation of prostate cancer cell attachment to matrix by versican.
PMID 12941795·Cancer Res·2003
8-other
Developmental expression patterns of Beta-ig (betaIG-H3) and its function as a cell adhesion protein.
PMID 12963107·Mech Dev·2003
7-preclinical
The extracellular matrix protein betaIG-H3 is expressed at myotendinous junctions and supports muscle cell adhesion.
PMID 12838408·Cell Tissue Res·2003
7-preclinical
An integrin binding peptide reduces rat CA1 hippocampal long-term potentiation during the first few minutes following theta burst stimulation.
PMID 12633887·Neurosci Lett·2003
7-preclinical
Temporal effects of cell adhesion on mechanical characteristics of the single chondrocyte.
PMID 12507584·J Orthop Res·2003
7-preclinical
Quantification of varying adhesion levels in chondrocytes using the cytodetacher.
PMID 12108844·Ann Biomed Eng·2002
4-observational
Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer.
PMID 11948113·Clin Cancer Res·2002
8-other
Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering.
PMID 11774300·J Biomed Mater Res·2002
7-preclinical
The process of reducing CA1 long-term potentiation by the integrin peptide, GRGDSP, occurs within the first few minutes following theta-burst stimulation.
PMID 11687398·Biol Bull·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- MSC10 5530, 1 UNIVERSITY OF NEW MEXICO
ALBUQUERQUE, NM 87131 - Phone
- (505) 272-6225
Quick Facts
- NPI
- 1053638981
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile